ERBB2 and breast cancer: Based on past led investigations, between all the samples of breast cancer, the Triple negative has a weaker forecast and a lower durability with the members in our research, the overall durability and disease-free durability got was the equal in both collections of Triple negative and another negative, indicating that the basis of this relationship was apparently the attendance of HER2 + subgroup in the non-Triple negative collection, which has pointed to the durability of cases in another negative collection, which was related to the Triple negative collection.